Cyclo(Arg-Pro) (TFA)

• UNSPSC Description:

  Cyclo(Arg-Pro) (Cyclo(Pro-Arg)) TFA is a chitinase inhibitor. Cyclo(Arg-Pro) TFA inhibits cell separation of Saccharomyces cerevisiae, without affecting its growth. Cyclo(Arg-Pro) TFA inhibits the morphological change of Candida albicans from yeast form to filamentous form[1].

• Target Antigen:

  Parasite

• Type:

  Peptides

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/cyclo-arg-pro-tfa.html

• Purity:

  98.04

• Solubility:

  H2O : 100 mg/mL (ultrasonic)

• Smiles:

  N/C(N)=N\CCC[C@@H]1NC([C@@](CCC2)([H])N2C1=O)=O.O=C(O)C(F)(F)F

• Molecular Weight:

  367.32

• References & Citations:

  [1]Izumida H, et al., The effect of chitinase inhibitors, cyclo(Arg-Pro) against cell separation of Saccharomyces cerevisiae and the morphological change of Candida albicans. J Antibiot (Tokyo). 1996 Aug;49(8):829-31.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

• Clinical Information:

  No Development Reported